Loading
Total declarations
Companies
▲ Purchases (2 ops.)
▼ Sales (1 ops.)
Latest filing published 23 Jun 2026 for Anika Therapeutics, Inc.. Read the official filing
Filing timeline
BuySaleJohn B. Henneman III
Insider track record
Disclosed buys
2
Disclosed sells
1
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
John B. Henneman III: trading record in brief
John B. Henneman III is a declared insider at 7 companies (board member); the most frequent names are Anika Therapeutics, Inc., Aprea Therapeutics, Inc. and R1 RCM Inc. /DE. The record holds 30 filings, for trades running from 4 January 2016 to 18 June 2026.
Market trades split into 2 purchases (€116k) and 1 sale. The totals exclude 1 filing filed without an amount. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket. The rest of the record consists of 22 share grants and 2 option exercises.
Most recently, on 23 June 2026, the filings show a share grant in Anika Therapeutics, Inc. The latest purchase dates back some time: it was published 948 days ago, on 14 March 2024. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 2 days. For comparison, the SEC allows two business days to file a Form 4. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Companies and markets linked to John B. Henneman III
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations30 total
10,402 sharesCommon StockSEC:0001193125-26-279542:0
3,135 sharesCommon StockSEC:0001104659-26-075282:0
14,164 shares0Common StockSEC:0001171843-25-004067:0
18,841 shares0Common StockSEC:0000950170-25-088989:0
1,045 shares0Common StockSEC:0001104659-25-057815:0
87,765 shares@ US$14.3090.9% of flowCommon StockSEC:0000950170-24-128856:0
5,771 shares0Common StockSEC:0001171843-24-003906:0
1,045 shares0Common StockSEC:0001104659-24-073941:0
15,152 shares@ US$12.87100.0% of flowCommon StockSEC:0000950170-24-075301:0
15,651 shares0Common StockSEC:0001628280-24-025050:0
6,860 shares@ US$7.29100.0% of flowCommon StockSEC:0001104659-24-034671:0
Canonical exit: 11 Jun 2024 (T+90)
500 shares0Common StockSEC:0001104659-23-095019:0
50,000 shares@ US$2.619.1% of flowCommon StockSEC:0001628280-23-028615:0
6,500 shares0Common StockSEC:0001171843-23-003959:0
11,324 shares0Common StockSEC:0001628280-23-019151:0
14,354 shares0Common StockSEC:0001209191-23-008128:0
82,654 sharesCommon StockSEC:0001637761-23-000041:0
14,052 shares0Common StockSEC:0001209191-23-002654:0
5,995 shares0Common StockSEC:0001104659-22-084765:0
54,751 sharesCommon StockSEC:0000899243-22-023862:0
60,790 sharesCommon StockSEC:0000899243-22-023836:0
7,954 shares0Common StockSEC:0001171843-22-004299:0
15,943 shares0Common StockSEC:0001637761-22-000096:0
5,151 sharesCommon StockSEC:0001628280-22-015245:0
4,610 shares0Common StockSEC:0001567619-21-012875:0
25 of 30 declarations
